寧水集團(603700.SH):控股股東及其一致行動人合計持股從46.01%減至44.83%
格隆匯3月16日丨寧水集團(603700.SH)公佈,公司於2023年3月15日收到信息披露義務人通知,信息披露義務人及其一致行動人自2023年2月28日至2023年3月15日期間,通過大宗交易方式合計減持公司股份2,386,000股,佔公司總股本的1.17%。此次權益變動屬於控股股東及其一致行動人減持股份及一致行動人之間內部轉讓。
公司控股股東張世豪、王宗輝、徐雲、王開拓、趙紹滿、張琳及其一致行動人張蕾、王菟瑩、上海藍墨投資管理有限公司-藍墨私享7號私募證券投資基金合計持有公司股份比例從46.01%減少至44.83%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.